RecruitingNCT07211438
Safety monitoring during psilocybin therapy for treatment-resistant depression
About this title
Read the official source — NCT07211438Medication studyAges 18–70Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 70 years.
What will I do during this study?
Participants receive 25 mg of psilocybin with either safety monitoring or psychedelic-assisted therapy support. The study compares these two support approaches; the registry entry reviewed does not give the number or timing of sessions.
- Listed locations
- Toronto and 1 more locationSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 3, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT07211438
- Official title
Show the full official title
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin.
Who can participate?
Listed age limits: 18 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
